|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Agile Therapeutics Inc (AGRX) |
|
|
$0.21 0.00 (0.00%) as of 4:30 Mon 4/10
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
87,300,000 |
| Market
Cap: |
18.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2066 - $0.2066 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Agile Therapeutics is a women's healthcare company. Co.'s primary product candidate, Twirla, is a once-weekly prescription combination hormonal contraceptive patch. It delivers a dose of estrogen that is consistent with commonly prescribed combined hormonal contraceptives. Co.'s pipeline consists of two classes of product candidates: Co.'s potential product pipeline consists of two types of product candidates: a progestin-only contraceptive patch and potential Twirla line extensions. These potential product candidates are designed to address market needs and provide additional non-daily contraceptive options. Including AG200-15 Extended Regimen, AG200-SmP, and AG200-15 ER SmP.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Coiante Scott M |
Chief Financial Officer |
• – – |
2023-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,080 |
|
- |
|
| Coiante Scott M |
Chief Financial Officer |
• – – |
2023-08-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80 |
|
- |
|
| Korner Paul |
Chief Medical Officer |
• – – |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
13,500 |
|
- |
|
| Gilmore Geoffrey |
Chief Administrative Officer |
• – – |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,216 |
20,256 |
|
- |
|
| Conway Robert G |
Chief Supply Chain Officer |
• – – |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
13,529 |
|
- |
|
| Welsh Amy |
Chief Commercial Officer |
• – – |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
13,500 |
|
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
46,463 |
47,749 |
|
- |
|
| Torrente Josephine |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
988 |
|
- |
|
| Hubbard John W |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
976 |
|
- |
|
| Fischer Seth H.z. |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
976 |
|
- |
|
| Barbari Sharon Surrey |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
974 |
|
- |
|
| Carson Sandra |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
935 |
974 |
|
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2022-08-26 |
4 |
B |
$0.45 |
$22,500 |
D/D |
50,000 |
64,343 |
2.81 |
-31% |
|
| Hubbard John W |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,066 |
|
- |
|
| Barbari Sharon Surrey |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
1,952 |
|
- |
|
| Torrente Josephine |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,659 |
|
- |
|
| Fischer Seth H.z. |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,066 |
|
- |
|
| Tursi James Patrick |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,066 |
|
- |
|
| Shetty Ajit |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,241 |
|
- |
|
| Carson Sandra |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
1,952 |
|
- |
|
| Edelman Joseph |
10% Owner |
– – • |
2021-10-13 |
4 |
B |
$0.85 |
$4,874,376 |
I/I |
5,734,560 |
21,654,485 |
1.5 |
-63% |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2021-10-13 |
4 |
B |
$0.00 |
$0 |
D/D |
58,824 |
573,734 |
2.73 |
-63% |
|
| Reilly Dennis |
Chief Financial Officer |
• – – |
2021-10-13 |
4 |
B |
$0.00 |
$0 |
D/D |
58,824 |
285,130 |
2.66 |
-63% |
|
| Torrente Josephine |
Director |
– • – |
2021-10-07 |
4 |
A |
$0.00 |
$0 |
D/D |
79,593 |
79,593 |
|
- |
|
| Altomari Alfred |
Chief Executive Officer |
• • – |
2021-07-29 |
4 |
B |
$1.26 |
$33,096 |
D/D |
26,200 |
514,910 |
2.81 |
-42% |
|
122 Records found
|
|
Page 1 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
